To stop the production of its vaccine AstraZeneca The US government has taken action against the coronavirus at the Baltimore plant.
In fact, according to the New York Times, the management of the factory was assigned to Johnson & Johnson, which had seen 15 million doses of its own vaccine destroyed by mistake.
J&J said in a statement that it “assumes full responsibility” for the production of the active substance in its vaccine “at the facility of Emergent BioSolutions Inc.”.
He did not specify whether he would take full control of the factory. The company did not respond when asked by Reuters to clarify this via email.
According to the New York Times, AstraZeneca said it would work with the US government to find another facility to produce its vaccine. The company did not respond when asked by Reuters to comment on the decision.
The move by the US Department of Health means that the Emergent BioSolutions plant will now manufacture exclusively the Johnson & Johnson vaccine, which is given in a single dose. The aim is to avoid confusion in the future such as the one that led to the destruction of the 15 million doses, the newspaper wrote, citing two top executives of the federal health services.
This week, the presidency adviser on tackling the new coronavirus pandemic, Dr. Anthony Fauci said the United States may not need the AstraZeneca vaccine for the new coronavirus, even if it obtains approval from the regulatory body.
Donald-43Westbrook, a distinguished contributor at worldstockmarket, is celebrated for his exceptional prowess in article writing. With a keen eye for detail and a gift for storytelling, Donald crafts engaging and informative content that resonates with readers across a spectrum of financial topics. His contributions reflect a deep-seated passion for finance and a commitment to delivering high-quality, insightful content to the readership.
